REQUEST A DEMO
Total
USD $0.00
Search more companies

FEDBA Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: FEDBA Pharma Gyogyszerkereskedelmi Bt. Profile Updated: August 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

FEDBA Bt. is a company based in Hungary, with its head office in Opalyi. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on November 01, 1996. The total number of employees is currently 4 (2024). From the latest financial highlights, FEDBA Bt. reported a net sales revenue increase of 6.6% in 2023. A growth of 29.03% was recorded in its total assets. The net profit margin of FEDBA Bt. increased by 16.29% in 2023.

Headquarters
Arpad u. 58.
Opalyi; Szabolcs-Szatmar-Bereg; Postal Code: 4821

Contact Details: Purchase the FEDBA Bt. report to view the information.

Basic Information
Total Employees:
Purchase the FEDBA Bt. report to view the information.
Outstanding Shares:
Purchase the FEDBA Bt. report to view the information.
Registered Capital:
Purchase the FEDBA Bt. report to view the information.
Incorporation Date:
November 01, 1996
Key Executives
Company Performance
Financial values in the chart are available after FEDBA Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.6%
Total operating revenue
6.34%
Operating profit (EBIT)
705.8%
EBITDA
451.84%
Net Profit (Loss) for the Period
964.91%
Total assets
29.03%
Total equity
31.68%
Operating Profit Margin (ROS)
12.03%
Net Profit Margin
16.29%
Return on Equity (ROE)
21.09%
Quick Ratio
0.13%
Cash Ratio
2.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?